Vanderbilt-Ingram Cancer Center

Vanderbilt-Ingram names William Tansey associate director for Shared Resources and Douglas Kojetin as co-leader of the Genome Maintenance Research Program. The Genome Maintenance Research Program is focused on understanding how DNA is damaged, repaired, packaged, expressed and replicated. Read More

Scott Hiebert, Hortense B. Ingram Chair in Cancer Research, has been named Chief Scientific Officer of the  Cancer Prevention and Research Institute of Texas. Hiebert served as chair of the National Cancer Advisory Board and brought global recognition to the Vanderbilt-Ingram Cancer Center during his 28 years at Vanderbilt. Read More

A recent paper from the lab of Emily Hodges looks at how two types of epigenetic changes act together but on different time scales to affect gene expression during cell differentiation. Read More

On-demand, professional development training for researchers via bite-sized, on-demand courses available for free. Courses include ‘Finding Funding Opportunities’, ‘Publishing a Research Paper’, ‘Managing Research Data to Unlock its Full Potential’, and more. Read More

Gary Sulikowski, Stevenson Professor of Chemistry, was named director of the Vanderbilt Institute for Chemical Biology in 2017. Since then, he has stewarded VICB’s growth and research operations. He shares how VICB has contributed to translational research, some of the research he's most excited about, and what makes Vanderbilt a rare place where powerful collaborative research can achieve its potential. Read More

It started with a hacksaw and a multimillion-dollar instrument. Richard Caprioli, then a postdoctoral fellow, was given the saw to cut the instrument in half during his first day of his postdoctoral studies. It was the day that Caprioli, now Stanford Moore Professor of Biochemistry, developed a desire to “do innovative things” with mass spectrometry instruments.” This yearning resulted in him becoming a pioneer of new mass spec techniques, including imaging mass spec. Read More

Leader in the field of ribosome biogenesis, Katrin Karbstein has joined the School of Medicine Basic Sciences as Ingram Professor of Cancer Research and professor of biochemistry. Her work has revealed the intricate details of ribosome biogenesis and revealed how misassembled ribosomes contribute to disease. She is also a community leader and mentor to emerging scholars. Read More

Foundational research from the Hiebert lab reveals genetic targets that can be leveraged to identify therapies that affect lymphoma cell growth. Read More